Year | Multi-drug resistance in uropathogenic bacteria (MDR in BSIs) | ||||||||
---|---|---|---|---|---|---|---|---|---|
E. colin (%)1 | Klebsiellaspp. n (%)1 | Enterobacterspp. n (%)1 | Pseudomonasspp. n (%)1 | Citrobacter n (%)1 | Other GNB n(%)1 | Salmonella sppn (%) | Staphylococcus aureusn (%) | CoNs (%) | |
≤ 2016 | 3(42.9) | 23(92.0) | 3(100) | 2(100) | 1(100) | 6(75) | 2(66.7) | 7(70.0) | 25 (41.7) |
2017–2018 | 6(85.7) | 14(93.3) | 2(66.7) | 5(100) | 6(100) | 4(80) | - | 6(75.0) | 9(60.0) |
2019–2020 | 21(89.7) | 35(94.6) | 7(100) | 16(94.1) | 16(94.1) | 10(90.9) | 3(100) | 10(71.4) | 35(71.4) |
> 2020 | 26(89.7) | 32(80.0) | 16(94.1) | 9(100) | 22(95.7) | 11(91.7) | 19(76.0) | 10(66.7) | 50(76.9) |
P value | 0.012 (10.87)b | 0.174 (4.97) | 0.245 (4.16) | 0.808 (0.971) | 0.069 (7.08) | 0.681(1.50) | 0.576(1.10) | 0.980 (0.19) | < 0.001 (18.67) b |
Total | 56(84.8) | 104(88.9) | 28(93.3) | 32(97.0) | 45(93.8) | 31(86.1) | 24(77.4) | 33(70.2) | 119(63.0) |